drugset
drugset / Trial / NCT04047446

Liposomal Bupivacaine vs Dexamethasone ISB

NCT04047446 ↗

Phase 4 Completed 112 enrolled Hospital for Special Surgery, New York
RandomizedParallel-groupDouble-blindTreatment

Summary

In this study, patients receiving shoulder arthroscopy will receive an interscalene block for pain management containing either liposomal bupivacaine and standard bupivacaine or standard bupivacaine and dexamethasone. Patients will be followed up with to determine postoperative pain and block duration.

Timeline

Start
2019-07-11
Primary completion
2021-03-15
Completion
2021-03-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 133 mg Other
Comparator Dexamethasone Small molecule 4 mg Other
Comparator Bupivacaine Other / unclassified 5 ml Other
Comparator Bupivacaine Other / unclassified 15 ml Other

Indications

arthropathy